Literature DB >> 11382640

Sebaceous carcinoma of the eyelid associated with retinoblastoma.

T Kivelä1, S Asko-Seljavaara, U Pihkala, L Hovi, J Heikkonen.   

Abstract

OBJECTIVE: To analyze the association between retinoblastoma (Rb) and sebaceous carcinoma (SC) of the eyelid to improve surveillance of survivors of RB:
DESIGN: Case report and systematic literature review.
METHODS: Ten patients who had SC develop after Rb were identified by systematic literature review, and a child who died with lymph node, lung, and liver metastases 7 years after irradiation for Rb is described. The data were analyzed by univariate statistics, including cumulative frequency distribution plots and Kaplan-Meier analysis.
RESULTS: Of 11 children with SC of the eyelid who all had hereditary RB, 9 (82%; 95% confidence interval, 48-98) received a median of 46 Gy (range, 21-89) of radiotherapy at a median age of 16 months (range, 0.5-15 years) and had SC develop within the field of radiation. Their median age at diagnosis of SC was 14 years (range, 8-30 years), median diagnostic delay 12 months (range, 6 months-3 years), and median interval from irradiation 11 years (range, 5-26 years); 7 of them (78%; 95% confidence interval, 40-97) were diagnosed between 5 and 15 years after radiotherapy. SC also developed at the age of 32 and 54 years in two nonirradiated Rb patients. Five patients had regional lymph node metastases after a median time of 12 months (range, 1 month-24 years). The 5-year cumulative probability of survival was 87%.
CONCLUSIONS: SC of the eyelid may occur in patients with hereditary Rb regardless of primary treatment, especially within the field 5 to 15 years after radiotherapy.

Entities:  

Mesh:

Year:  2001        PMID: 11382640     DOI: 10.1016/s0161-6420(01)00555-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians.

Authors:  S Kaliki; A Ayyar; T V Dave; M J Ali; D K Mishra; M N Naik
Journal:  Eye (Lond)       Date:  2015-05-22       Impact factor: 3.775

2.  Low penetrance hereditary retinoblastoma in a family: what should we consider in the genetic counselling process and follow up?

Authors:  C Serrano; J Alonso; G Gómez-Mariano; E Aguirre; O Diez; N Gadea; N Bosch; J Balmaña; B Graña
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

3.  Periocular sebaceous gland carcinoma: A comprehensive review.

Authors:  Kaustubh Mulay; Ekta Aggarwal; Valerie A White
Journal:  Saudi J Ophthalmol       Date:  2013-07

4.  Early onset sebaceous carcinoma.

Authors:  Dongjin Sung; Sara A Kaltreider; Federico Gonzalez-Fernandez
Journal:  Diagn Pathol       Date:  2011-09-05       Impact factor: 2.644

5.  Left Buttock Sebaceus Carcinoma: A Case Report and Review of the Literature.

Authors:  Răzvan Mercuţ; Mihaela Ionescu; Cristiana Simionescu; Vlad Pîrvănescu; Maria Filoftea Mercuţ; Alexandru Gogănău; Marius Eugen Ciurea
Journal:  Curr Health Sci J       Date:  2021-12-31

6.  Increased Risk of Skin Cancer in 1,851 Long-Term Retinoblastoma Survivors.

Authors:  Ruth A Kleinerman; Sara J Schonfeld; David H Abramson; Jasmine H Francis; Johanna M Seddon; Lindsay M Morton; Margaret A Tucker
Journal:  J Invest Dermatol       Date:  2021-06-18       Impact factor: 7.590

7.  Sebaceous carcinoma of the suprapubic area in a liver transplant recipient.

Authors:  Bommie F Seo; Hyun Wook Jung; Ik Kyun Choi; Jong Won Rhie
Journal:  Ann Dermatol       Date:  2014-06-12       Impact factor: 1.444

8.  MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma.

Authors:  John C Bladen; Jun Wang; Ajanthah Sangaralingam; Mariya Moosajee; Caroline Fitchett; Claude Chelala; Michele Beaconsfield; Edel A O'Toole; Michael P Philpott; Daniel G Ezra
Journal:  Sci Rep       Date:  2018-05-14       Impact factor: 4.379

9.  Establishment and Characterization of a Novel Human Ocular Adnexal Sebaceous Carcinoma Cell Line.

Authors:  Andrew J Rong; Ryan A Gallo; Michelle G Zhang; Ravi Doddapaneni; Anthony J Griswold; John Y Lee; Stefan Kurtenbach; Sander R Dubovy; David T Tse; Daniel Pelaez
Journal:  Transl Vis Sci Technol       Date:  2021-05-03       Impact factor: 3.283

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.